Filing Details

Accession Number:
0001140361-17-044911
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-04 18:00:18
Reporting Period:
2017-11-30
Accepted Time:
2017-12-04 18:00:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1500399 Giovani Twigge Idexx Laboratories, Inc.
One Idexx Drive
Westbrook ME 04092
Chief Human Resources Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-11-30 1,442 $156.09 14,960 No 4 S Direct
Common Stock Disposition 2017-11-30 558 $156.01 14,402 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the weighted average sales price of the shares sold ranging from a low of $156.05 to a high of $156.155 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  2. Includes a total of 70 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2017 and September 29, 2017.